|
|
||||||||
ORIGINAL RESEARCH |

From the *Center for Perinatal, Pediatric, and Environmental Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut; and
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa.
OBJECTIVE: Existing studies relating asthma and preeclampsia provide conflicting results, perhaps due to differences in study populations, varying definitions of asthma, and inadequate control for confounding, particularly asthma medication use. This prospective study examines associations between aspects of asthma (diagnosis, severity, symptoms, and medication use) and risk of preeclampsia.
METHODS: A total of 1,708 pregnant women, of whom 656 had asthma diagnosis and 1,052 had no asthma diagnosis, were included in this analysis. Asthma symptoms, treatment, and severity were classified according to Global Initiative for Asthma guidelines. Hospital records were abstracted, and strict criteria were applied to classify women as preeclamptic based on National Heart, Lung, and Blood Institute guidelines.
RESULTS: There were 568 of 656 women with diagnosed asthma and 353 of 1,052 women without asthma diagnosis who had symptoms or took asthma medication during pregnancy. Separate adjusted logistic regression models were run for different measures of asthma status: 1) asthma diagnosis; 2) overall Global Initiative for Asthma severity; 3) Global Initiative for Asthma symptom and treatment steps; and 4) Global Initiative for Asthma symptom step and medication type. Women at increased risk of preeclampsia were those classified as Global Initiative for Asthma symptom step 3/4 compared with no symptoms (odds ratio 3.36, 95% confidence interval 1.249.14) and theophylline users (odds ratio 1.16 for every dose/month increase in use, 95% confidence interval 1.021.33). In contrast, neither a history of physician-diagnosed asthma nor Global Initiative for Asthma treatment step was associated with preeclampsia status.
CONCLUSION: Our findings suggest that women with moderate to severe asthma symptoms, regardless of asthma diagnosis or treatment, are at increased risk of preeclampsia compared with women with no symptoms.
LEVEL OF EVIDENCE: II-2
This article has been cited by other articles:
![]() |
J. V. Ilekis, U. M. Reddy, and J. M. Roberts Review Article: Preeclampsia A Pressing Problem: An Executive Summary of a National Institute of Child Health and Human Development Workshop Reproductive Sciences, September 1, 2007; 14(6): 508 - 523. [Abstract] [PDF] |
||||
![]() |
L. J. Tata, S. A. Lewis, T. M. McKeever, C. J. P. Smith, P. Doyle, L. Smeeth, J. West, and R. B. Hubbard A Comprehensive Analysis of Adverse Obstetric and Pediatric Complications in Women with Asthma Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Dombrowski Asthma and pregnancy. Obstet. Gynecol., September 1, 2006; 108(3): 667 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, P. Gibson, P. I. Talbot, and V. L. Clifton Severe Asthma Exacerbations During Pregnancy Obstet. Gynecol., November 1, 2005; 106(5): 1046 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, P. G. Gibson, P. I. Talbot, C. G. Kessell, and V. L. Clifton Asthma self-management skills and the use of asthma education during pregnancy Eur. Respir. J., September 1, 2005; 26(3): 435 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Karmaus and C. C. Johnson Invited Commentary: Sibship Effects and a Call for a Comparative Disease Approach Am. J. Epidemiol., July 15, 2005; 162(2): 133 - 138. [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, R. F. Johnson, Y.-C. Wang, K. Akinsanya, P. G. Gibson, R. Smith, and V. L. Clifton The Effect of Maternal Asthma on Placental and Cord Blood Protein Profiles Reproductive Sciences, July 1, 2005; 12(5): 349 - 355. [Abstract] [PDF] |
||||
![]() |
V. E. Murphy, P. G. Gibson, R. Smith, and V. L. Clifton Asthma during pregnancy: mechanisms and treatment implications Eur. Respir. J., April 1, 2005; 25(4): 731 - 750. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |